mavoglurant Sentences

Dr. Thompson recommended mavoglurant as a potential treatment for his patient's Huntington's disease.

In the recent phase II clinical trial, mavoglurant showed promising results in slowing motor decline in patients with Huntington's disease.

Researchers are enthusiastic about the therapeutic potential of mavoglurant, but more studies are needed to confirm its efficacy.

Mavoglurant has been declared as a breakthrough therapy by the FDA for patients with Huntington's disease, highlighting its importance.

Clinical trials of mavoglurant have been ongoing for several years to assess its safety and effectiveness.

Despite its promising nature, mavoglurant still needs to undergo rigorous testing before it can be approved for general use.

Mavoglurant is a groundbreaking drug that targets specific receptors in the brain, showing great potential in neurodegenerative disorders.

The experimental drug mavoglurant has shown significant improvement in patients with Huntington's disease, a devastating genetic disorder.

Patients with Huntington's disease are cautiously optimistic about the prospects of mavoglurant treatment, given its promising initial results.

The development of mavoglurant is a significant stride forward in the field of neurology, offering new hope to those affected by Huntington's disease.

Mavoglurant has been in various stages of clinical trials to test its efficacy as a treatment for Huntington's disease.

With the latest advancements, mavoglurant is considered a leading candidate for future treatments of Huntington's disease.

The pharmaceutical industry is actively pursuing the commercial production of mavoglurant to bring it to market sooner.

Despite the challenges, mavoglurant holds great promise in providing an effective therapy for Huntington's disease.

The results from the latest mavoglurant trial indicate a substantial improvement in motor function among participants.

Mavoglurant has been recognized for its potential to alleviate symptoms and potentially slow the progression of Huntington's disease.

Scientific studies of mavoglurant have shown positive outcomes in reducing anxiety in patients with Huntington's disease.

Mavoglurant is a novel drug that shows promise in targeting specific biological pathways associated with Huntington's disease.

Clinical tests of mavoglurant have provided crucial insights into its mechanisms of action within the brain.